As of January 2026 Acrivon Therapeutics has a market cap of A$91.77 Million. This makes Acrivon Therapeutics the world's 9657th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 20th, 2026 the market cap of Acrivon Therapeutics was reported to be: